
Sign up to save your podcasts
Or


A drug considered to be a ‘huge breakthrough’ for the treatment of Alzheimer’s, Lecanemab, has been approved for use in the UK - but it’s been announced that it won’t be available on the NHS in England.
David Thomas, Head of Policy & Public Affairs at Alzheimer’s Research UK, tells Tech & Science Daily why it’s a bittersweet moment for people living with dementia.
World-leading sleep expert and neuroscientist Professor Russell Foster from Oxford University, tells our sister podcast Brave New World, why napping is seen as controversial in the sleep science community. Listen to the full episode here.
Research suggests that the Moon’s south pole was once covered in an ocean of magma.
Also in this episode:
Follow us on X or on Threads.
Hosted on Acast. See acast.com/privacy for more information.
By The Evening Standard3.8
55 ratings
A drug considered to be a ‘huge breakthrough’ for the treatment of Alzheimer’s, Lecanemab, has been approved for use in the UK - but it’s been announced that it won’t be available on the NHS in England.
David Thomas, Head of Policy & Public Affairs at Alzheimer’s Research UK, tells Tech & Science Daily why it’s a bittersweet moment for people living with dementia.
World-leading sleep expert and neuroscientist Professor Russell Foster from Oxford University, tells our sister podcast Brave New World, why napping is seen as controversial in the sleep science community. Listen to the full episode here.
Research suggests that the Moon’s south pole was once covered in an ocean of magma.
Also in this episode:
Follow us on X or on Threads.
Hosted on Acast. See acast.com/privacy for more information.

891 Listeners

57 Listeners

37 Listeners

2,083 Listeners

57 Listeners

35 Listeners

424 Listeners

396 Listeners

356 Listeners

96 Listeners

172 Listeners

641 Listeners

2,547 Listeners

1 Listeners

22 Listeners

111 Listeners

177 Listeners

0 Listeners

0 Listeners

9 Listeners

2 Listeners

3 Listeners